Sun Exposure and Skin Aging: The UV Damage Mechanism Explained
UV exposure drives 80 to 90 percent of visible facial aging, making sun protection the single highest-leverage anti-aging behavior available without a prescription.
UVA penetrates window glass and reaches the collagen-rich dermis, meaning indoor and incidental daily exposure accumulates damage that most people never account for.
Photoaging accelerates the same core hallmarks of aging as systemic disease: epigenomic drift, cellular senescence, telomere attrition, and mitochondrial dysfunction.
A randomized controlled trial confirmed daily sunscreen use produces measurably less skin aging over time, not a cosmetic claim but prospective clinical evidence.
Topical rapamycin and retinoids work at the level of gene regulation and senescent cell clearance, not surface texture, making them mechanistically distinct from most cosmetic skincare.
Metabolic health directly affects skin aging trajectory: advanced glycation end-products cross-link collagen and compound UV-induced matrix degradation.
The goal is UV optimization, not UV elimination: enough sunlight for vitamin D synthesis and cardiovascular benefit, calibrated to phototype and latitude, with consistent photoprotection layered on top.
Stand in direct sunlight for long enough and the warmth feels almost therapeutic. In small, calibrated doses, it is. But beneath that agreeable sensation, ultraviolet radiation is doing something far less benign: dismantling the molecular architecture that keeps skin firm, resilient, and biologically young. Sun exposure skin aging, clinically called photoaging, accounts for an estimated 80 to 90 percent of visible facial aging in light-skinned populations, a figure that separates it from virtually every other environmental insult the body endures over a lifetime. [1] This is not a cosmetic footnote. It is a signal about how the biology of aging responds to one of the most pervasive and modifiable exposures in daily life.
Longevity medicine has long focused its attention inward, on mitochondrial efficiency, metabolic signaling, hormonal decline, and cellular senescence. Skin, the body's largest organ, has often been treated as peripheral to that conversation. That framing is changing. The mechanisms by which UV radiation ages skin overlap substantially with core hallmarks of aging: oxidative stress, epigenomic dysregulation, chronic low-grade inflammation, telomere attrition, and the accumulation of senescent cells. Photoaging is not a superficial problem. It is a window into systemic aging biology, and protecting against it is a legitimate longevity lever.
What UV Radiation Actually Does to Skin
Sunlight reaches the skin as a spectrum. Ultraviolet B radiation, which carries shorter wavelengths between 280 and 315 nanometres, penetrates to the epidermis, the outermost cellular layer of the skin. Ultraviolet A radiation, with longer wavelengths between 315 and 400 nanometres, reaches deeper, into the dermis, where collagen and elastin fibers give skin its structure and elasticity. Both subtypes cause damage, but through different mechanisms, and their combined effect over decades is cumulative and largely irreversible without intervention. [2]
UVB radiation acts more like a blunt instrument. It is directly absorbed by DNA in epidermal cells, generating photoproducts called cyclobutane pyrimidine dimers, places where adjacent thymine bases on the DNA strand fuse together like two pages of a book glued shut. The cell's repair machinery can fix many of these lesions, but under high or repeated UV exposure, the error rate climbs. Mutations accumulate, particularly in the TP53 tumor suppressor gene, and that is where the carcinogenesis pathway begins. [3]
UVA radiation operates through a subtler but equally destructive route. Rather than attacking DNA directly, UVA photons excite endogenous chromophores in the skin, molecules like porphyrins and flavins that absorb light energy and then transfer it to oxygen, generating reactive oxygen species (ROS). These include the superoxide radical, hydrogen peroxide, and the highly reactive hydroxyl radical, a molecule so chemically aggressive it reacts with nearly everything it contacts within a few nanometres. The hydroxyl radical does not wait to find DNA. It attacks collagen fibers, membrane lipids, and mitochondrial proteins with equal indiscrimination. Think of it as a spark inside a room filled with combustible material, the precise location of ignition matters less than the fact that everything around it is flammable. [4]
Beyond direct molecular damage, UV radiation activates a cascade of inflammatory signaling through cell surface receptors. Keratinocytes and fibroblasts, the primary cellular workers of the epidermis and dermis respectively, upregulate transcription factors including AP-1 and NF-kB in response to UV exposure. These transcription factors drive the production of matrix metalloproteinases (MMPs), a family of enzymes whose normal role is controlled remodeling of the extracellular matrix. Under chronic UV stimulation, MMPs are produced at levels that degrade collagen far faster than fibroblasts can synthesize new fibers. The result is net collagen loss, the biological substrate of wrinkles, sagging, and the leathered texture characteristic of photoaged skin. [5]
The Epigenomic Dimension: UV Radiation as an Aging Accelerant
Damage to individual molecules is one story. The deeper story is what UV radiation does to the regulatory machinery that controls how genes are expressed across decades. The epigenome, the system of chemical tags and structural modifications that sit on top of the DNA sequence and determine which genes are switched on or off, is exquisitely sensitive to environmental insults. UV exposure is one of the most potent environmental modifiers of skin epigenomics studied to date. [6]
DNA methylation, one of the best-characterized epigenetic marks, shows characteristic patterns in photoaged skin that mirror what is seen in chronologically aged skin more broadly. Specific CpG sites across the genome become hypomethylated, while others gain methylation where there was none, a reshuffling of the epigenetic landscape that disrupts normal gene regulation. Biological age clocks, algorithms trained to predict chronological age from DNA methylation patterns across tissues, register photoaged skin as significantly older than protected skin from the same individual. One study comparing sun-exposed facial skin to sun-protected buttock skin in the same subjects found an epigenetic age gap of several years attributable to UV exposure alone. [6]
Biological age clocks register photoaged skin as significantly older than sun-protected skin from the same individual, an epigenetic gap attributable to UV exposure alone.
This matters because epigenetic aging is not merely a measurement artifact. It is increasingly understood as a mechanistic driver of cellular dysfunction, not just a passive readout of wear and tear. Cells with a dysregulated epigenome show impaired DNA repair, altered metabolism, and disrupted communication with neighboring cells. In skin, this translates to fibroblasts that are less responsive to growth signals, keratinocytes that differentiate abnormally, and a tissue microenvironment primed for chronic inflammation. UV radiation, in this frame, is not just damaging molecules. It is accelerating the biological clock in the largest organ in the body.
Telomere shortening adds another layer to this picture. Telomeres are the repetitive DNA sequences that cap the ends of chromosomes, preventing them from being recognized as broken strands and triggering a DNA damage response. Each time a cell divides, telomeres shorten slightly. When they become critically short, the cell either enters senescence or undergoes apoptosis. UV-induced ROS accelerate telomere attrition preferentially at guanine-rich sequences, which are disproportionately represented in telomeric DNA, shortening the cellular lifespan of skin cells faster than chronological aging would predict. [7]
Cellular Senescence: When Skin Cells Stop Working But Refuse to Leave
One of the most consequential downstream effects of chronic UV exposure is the accumulation of senescent cells in skin tissue. Cellular senescence is a state in which a damaged or stressed cell permanently exits the cell cycle. It stops dividing, but it does not die. Instead, it persists in the tissue and begins secreting a cocktail of inflammatory cytokines, proteases, and growth factors collectively called the senescence-associated secretory phenotype, or SASP. In small quantities and at the right time, senescence and SASP serve important functions in wound healing and tumor suppression. When senescent cells accumulate chronically in aging tissue, SASP becomes a source of persistent, low-grade inflammation that degrades the surrounding extracellular matrix and impairs the function of neighboring healthy cells. [8]
UV radiation drives senescence through multiple convergent pathways. UVB-induced DNA damage activates the p53-p21 axis, a well-characterized tumor suppressor pathway that halts cell division in damaged cells. UVA-generated ROS activate the p16-Rb pathway, a parallel senescence enforcement mechanism. The result is a skin tissue progressively colonized by cells that are metabolically active, secreting inflammatory mediators, but no longer capable of performing repair and regeneration functions. This is a central mechanism of photoaging at the tissue level, and it is the same mechanism targeted by senolytic strategies being explored in systemic longevity medicine. [8]
Mitochondrial dysfunction is tightly intertwined with this process. UV-generated ROS damage mitochondrial DNA, which, unlike nuclear DNA, has limited repair capacity. Mitochondria in chronically UV-exposed skin show characteristic deletions, reduced electron transport chain efficiency, and impaired ATP production. This bioenergetic deficit compounds the problem: fibroblasts with dysfunctional mitochondria produce less collagen, handle oxidative stress less effectively, and are more prone to entering senescence. [9]
The Cumulative Exposure Problem: Dose, Timing, and Irreversibility
A single sunburn in childhood does measurable damage. But the more insidious driver of photoaging is not the acute burns most people remember. It is the chronic, subclinical UV exposure that accumulates across a lifetime: the commute through a car window, the afternoon walk without sunscreen, the years of outdoor recreation before the science was widely understood. Epidemiological estimates suggest that up to 80 percent of cumulative lifetime UV exposure occurs incidentally rather than during deliberate sun-seeking activities. [1]
Glass is a useful illustration of this underappreciated exposure. Standard window glass blocks nearly all UVB radiation, which is why most people feel protected sitting near a window. It transmits a substantial fraction of UVA, the deeper-penetrating, collagen-degrading wavelength. Drivers in the United States show measurably greater photoaging on the left side of the face, the side exposed through the driver's window, compared to the right. This asymmetry in aging, documented on physical examination and confirmed by photographic analysis, is a visible record of decades of cumulative incidental UVA exposure. [10]
Drivers show measurably greater photoaging on the left side of the face, the window side, a visible record of decades of cumulative incidental UVA exposure that most people never knew they were accumulating.
The timing of UV exposure across the lifespan introduces another important variable. Skin accumulated in early life appears to establish a kind of molecular memory: early UV damage primes the skin's epigenomic landscape and depletes stem cell pools in ways that compound over subsequent decades. Studies in mouse models demonstrate that neonatal UV exposure produces more aggressive and earlier-onset photoaging phenotypes than equivalent cumulative exposure beginning in adulthood. [5] The biology does not reset between exposures. It keeps score.
Irreversibility is the most clinically important aspect of this cumulative picture. The collagen lost to MMP activity cannot be fully replaced by fibroblasts that are themselves senescent or mitochondrially impaired. The epigenetic changes persist and propagate through cell divisions. Telomere attrition is a one-way process. This is not an argument for fatalism; protective and restorative interventions have genuine efficacy that will be discussed below. It is an argument for the urgency of prevention and the importance of starting early, because the longevity calculus here strongly favors accumulated protection over attempted repair.
Photoaging as a Systemic Aging Signal
Skin is sometimes dismissed in longevity discussions as a cosmetic concern, something separate from the metabolic, cardiovascular, and neurological dimensions of aging that receive more clinical attention. This framing misses the biological depth of the organ. Skin is immunologically active, hormonally responsive, and metabolically connected to systemic physiology in ways that make its accelerated aging relevant far beyond appearance.
Chronically inflamed, photoaged skin produces systemic cytokines. TNF-alpha, IL-1, and IL-6, the major pro-inflammatory mediators elevated in photoaged skin fibroblasts, are the same cytokines that drive inflammaging, the chronic low-grade systemic inflammation associated with accelerated biological aging and increased risk of cardiometabolic disease, neurodegeneration, and frailty. [11] There is no clean boundary between inflamed skin and systemic inflammation. The two are connected by the circulation, and what begins locally can propagate broadly.
The skin's immune function also declines with UV exposure. Langerhans cells, the dendritic cells that patrol the epidermis and serve as sentinels for the adaptive immune system, are depleted by UV radiation. This local immunosuppression is part of why UV exposure increases skin cancer risk, but it also contributes to the broader pattern of immune aging that makes older individuals more vulnerable to infection, malignancy, and autoimmune dysregulation. [3]
There is also a hormonal dimension. The skin is an active site of vitamin D synthesis, steroid hormone metabolism, and neuropeptide production. UV exposure stimulates endorphin release via a POMC (proopiomelanocortin)-mediated pathway, which may partly explain the addictive quality of sun exposure some individuals experience. [12] The same pathway drives melanogenesis and tanning, which represents the skin's protective response to UV damage, a biological shield built from the rubble of cellular stress. This is a reminder that not all UV-related biology is harmful; the challenge is maintaining the narrow window of benefit while minimizing the much wider domain of damage.
Evidence-Based Photoprotection: What the Research Supports
The evidence base for photoprotection as an anti-aging intervention is more robust than is commonly appreciated in longevity medicine circles, where injectable peptides and metabolic drugs tend to command more attention than sunscreen. A landmark randomized controlled trial published in Annals of Internal Medicine followed Australian adults over four and a half years and found that daily sunscreen use, assigned randomly, produced measurably less skin aging compared to discretionary use, with significant differences in skin texture and appearance quantified by dermatological assessment. This was a prospective, controlled, randomized study of sun protection as an anti-aging intervention, and its findings were unambiguous. [13]
Sunscreen mechanism matters. Most commercial formulations use either chemical UV-absorbing filters, which convert UV energy into heat, or physical mineral filters, primarily zinc oxide and titanium dioxide, which reflect and scatter UV photons before they reach the skin. Broad-spectrum formulations attenuate both UVB and UVA. The SPF number on a product label refers specifically to UVB protection; UVA protection is indicated by the PA rating system or the broad-spectrum designation. For photoaging prevention, UVA protection is arguably the more important variable given its ability to penetrate to the collagen-rich dermis. [14]
Protective clothing and behavioral modification compound the benefit of topical sunscreen. Ultraviolet-protective fabrics with an ultraviolet protection factor (UPF) rating provide consistent, non-degrading coverage. Sunscreen, by contrast, requires correct application volume (2 mg per cm² of skin, roughly a teaspoon for the face alone) and reapplication every two hours to maintain its rated protection. Most people apply approximately a quarter to half of the required amount, effectively reducing the real-world SPF of a labeled SPF 50 product to something closer to SPF 10 to 15. [14] This is not an argument against sunscreen; it is an argument for understanding its limitations and supplementing with other protective measures.
Antioxidant supplementation and topical application represent a complementary strategy, particularly for neutralizing UVA-driven ROS that physical and chemical filters do not entirely prevent. Topical vitamin C (L-ascorbic acid) at concentrations above 10 percent has documented efficacy in reducing UV-induced oxidative damage and stimulating collagen synthesis. Topical vitamin E and ferulic acid stabilize vitamin C and extend its photoprotective effect. Oral supplementation with antioxidants including polyphenols, carotenoids, and nicotinamide has demonstrated modest protective effects in human studies, though effect sizes are smaller than topical photoprotection. [15]
Nicotinamide deserves special attention. This B3 vitamin precursor to NAD+ has shown efficacy in reducing UV-induced immunosuppression, enhancing DNA repair in keratinocytes, and lowering rates of new non-melanoma skin cancer in high-risk populations. A randomized, double-blind trial in patients with a history of non-melanoma skin cancer found that oral nicotinamide 500 mg twice daily reduced the rate of new skin cancers by 23 percent over 12 months. [16] The mechanism involves improved energy availability for nucleotide excision repair, the cellular machinery responsible for removing UV-induced photoproducts from DNA, and connects directly to the broader NAD+ biology central to many longevity interventions.
Restorative Interventions: Reversing What Can Be Reversed
Prevention is the more powerful intervention, but the photoaging phenotype is not entirely fixed. Several evidence-based approaches can partially restore molecular and structural features of UV-damaged skin, with the strongest evidence concentrated in a relatively short list of compounds and modalities.
Retinoids remain the best-studied class of topical agents for photoaged skin. Tretinoin (all-trans retinoic acid), the pharmacologically active form, binds nuclear retinoic acid receptors in keratinocytes and fibroblasts and drives a program of gene expression that includes collagen synthesis upregulation, MMP inhibition, epidermal thickening, and normalization of keratinocyte differentiation. Randomized controlled trials consistently demonstrate improvement in fine lines, mottled pigmentation, and skin texture with 0.025 to 0.1 percent tretinoin cream applied nightly. The improvements are real, measurable by histology as well as clinical assessment, and reflect genuine tissue-level restoration. [17]
The mechanism of retinoid action in photoaged skin converges on several of the same molecular targets disrupted by UV exposure. AP-1 and NF-kB, the transcription factors upregulated by UV and responsible for MMP induction, are suppressed by retinoic acid signaling. Simultaneously, retinoic acid receptors compete with AP-1 for cofactors in a molecular tug-of-war that, with sustained retinoid use, begins to shift the balance toward matrix synthesis rather than degradation. This is not a superficial cosmetic effect. It is a pharmacological intervention at the level of gene regulation. [17]
Emerging evidence positions rapamycin, the mTOR inhibitor with established roles in longevity biology, as a promising topical agent for skin aging. mTOR signaling drives cellular senescence through multiple pathways, and its inhibition has been shown to clear senescent cells and restore tissue homeostasis in preclinical models. Topically applied rapamycin, formulated for skin penetration, has shown preliminary clinical evidence of reducing photoaging-associated features including skin thinning, loss of elasticity, and dyspigmentation, through mechanisms that include senolytic activity and autophagy induction in dermal fibroblasts. [18] Healthspan's Topical Rapamycin for Skin protocol applies this mechanism directly, delivering low-dose rapamycin in a formulation designed for dermal bioavailability, in the context of a supervised clinical program.
Autophagy, the cellular recycling process that clears damaged organelles and misfolded proteins, declines with age and is further suppressed by UV-induced oxidative stress. Stimulating autophagy in UV-damaged skin cells has been shown to reduce ROS accumulation, clear dysfunctional mitochondria via mitophagy, and reduce the SASP profile of senescent fibroblasts. [9] This connects the skin biology of photoaging to the broader cellular renewal pathways targeted by compounds like urolithin A, spermidine, and NAD+ precursors that are gaining traction in systemic longevity protocols.
For individuals managing broader longevity goals, systemic inflammation is a modifiable variable that directly affects skin aging trajectory. Metabolic health, adiposity, glycemic control, and hormonal status all influence inflammatory signaling in skin. The AGE (advanced glycation end-product) load in chronically hyperglycemic individuals accumulates in collagen fibers, cross-linking them into a rigid, disorganized matrix that compounds UV-induced collagen degradation. Maintaining metabolic health is therefore not only a cardiovascular and neurological imperative but also a photoaging mitigation strategy. Healthspan's Longevity Optimization program addresses these interconnected metabolic and inflammatory drivers in a structured clinical framework.
The Sun's Benefits: Holding the Balance
A rigorous account of UV biology must acknowledge the other side of the ledger. Sunlight is not unambiguously harmful, and an extreme avoidance posture creates its own set of risks. UVB-driven cutaneous vitamin D synthesis remains the most efficient source of this hormone-like compound for most people, and vitamin D deficiency is associated with increased risks of autoimmune disease, cardiovascular disease, and several cancers. [19]
Beyond vitamin D, emerging evidence identifies non-vitamin D pathways through which sunlight exposure confers cardiovascular benefit. Nitric oxide, stored in the skin as inorganic nitrite and nitrate, is mobilized by UV exposure and causes systemic vasodilation. An intervention study demonstrated that whole-body UVA exposure reduced mean arterial blood pressure by a clinically meaningful margin without changing vitamin D levels, suggesting a vitamin D-independent mechanism of cardiovascular benefit from sunlight. [20] This is biologically important context: the goal is not UV avoidance but UV optimization, enough exposure to capture systemic benefits while minimizing the cumulative dermal burden that drives photoaging and carcinogenesis.
That balance point varies by skin phototype, geographic latitude, season, time of day, and individual health status. Darker skin phototypes have substantially higher levels of epidermal melanin, which provides natural photoprotection equivalent to approximately SPF 13 and reduces, but does not eliminate, photoaging and UV-induced DNA damage. Lighter skin phototypes burn faster and accumulate photoaging damage faster, but also synthesize vitamin D more efficiently per unit of UV exposure. [19] A precision approach to sun exposure, calibrated to the individual's phototype, latitude, and health goals, is more clinically useful than categorical advice in either direction.
Photoaging as a Longevity Lever: The Clinical Frame
The epidemiology of photoaging carries a number sometimes lost in the cosmetic framing of the field: the biological mechanisms driving visible skin aging overlap substantially with the mechanisms driving systemic aging across tissues. ROS accumulation, senescent cell accumulation, epigenomic drift, telomere attrition, chronic inflammation, and mitochondrial dysfunction are not skin-specific pathologies. They are the hallmarks of aging, and UV radiation accelerates all of them in the body's largest and most environmentally exposed organ.
Managing sun exposure skin aging is therefore not simply about appearance, though the evidence that photoprotection measurably reduces visible aging is robust and clinically important in its own right. It is about removing one of the most preventable accelerants of biological aging from a system already navigating the intrinsic pressures of time. The skin's epigenetic age gap between UV-exposed and UV-protected tissue represents years of unnecessary biological aging. Closing that gap through consistent photoprotection, evidence-based topical and systemic support, and metabolic health optimization represents a measurable, accessible intervention in the trajectory of biological aging.
The longevity field is increasingly focused on identifying modifiable levers that shift the aging trajectory rather than merely treating its downstream consequences. Sun exposure sits at the intersection of biology and behavior, a daily environmental input whose modification requires no prescription, no injection, and no clinical infrastructure to begin. The evidence supporting that modification is decades old, replicated, and large in effect size. What it has often lacked is the framing that places it alongside the metabolic, hormonal, and cellular interventions that occupy longevity medicine's center of gravity. That framing is now warranted.
FAQ
Does sunscreen actually prevent skin aging, or is that a marketing claim?
A randomized controlled trial published in Annals of Internal Medicine demonstrated that daily sunscreen use produced significantly less skin aging over four and a half years compared to discretionary use, with measurable differences confirmed by dermatological assessment. This is not marketing. It is prospective, controlled trial evidence of a clinically meaningful anti-aging effect. [13]
What percentage of skin aging is caused by UV exposure?
Epidemiological research estimates that UV exposure accounts for 80 to 90 percent of visible facial aging in light-skinned populations, making it the dominant environmental driver of the photoaging phenotype by a substantial margin. [1]
What is the difference between UVA and UVB for skin aging?
UVB radiation primarily damages DNA in the outer epidermis and is the main driver of sunburn and skin cancer initiation. UVA radiation penetrates deeper into the dermis and generates reactive oxygen species that degrade collagen and elastin fibers, driving the structural changes most associated with visible skin aging. Both contribute to carcinogenesis. Broad-spectrum sun protection addresses both. [2]
Is photoaging reversible?
Some aspects of photoaged skin can be partially restored. Retinoids stimulate collagen synthesis and suppress matrix metalloproteinases, with histologically confirmed tissue improvements in randomized trials. Topical rapamycin shows early clinical evidence of reducing senescence-associated features. However, the epigenomic changes, telomere attrition, and collagen loss that accumulate over decades cannot be fully reversed. Prevention provides substantially greater benefit than post-hoc repair. [17]
How does sun exposure relate to systemic aging?
UV-driven damage in skin activates the same hallmarks of aging observed across all tissues: reactive oxygen species accumulation, cellular senescence, epigenomic dysregulation, telomere shortening, and chronic inflammation. Senescent skin cells secrete pro-inflammatory cytokines that enter systemic circulation, connecting photoaged skin to the inflammaging process implicated in cardiometabolic disease, neurodegeneration, and frailty. [11]
- Flament, F., Bazin, R., Laquieze, S., Rubert, V., Simonpietri, E., & Piot, B. (2013). Effect of the sun on visible clinical signs of aging in Caucasian skin. Journal of the American Academy of Dermatology, 68(6), 1005–1014. https://doi.org/10.1016/j.jaad.2012.09.056
- Gilchrest, B. A. (2019). Sun exposure and vitamin D sufficiency. New England Journal of Medicine, 380(9), e10. https://doi.org/10.1056/NEJMra1911534
- Noonan, F. P., & Bhagat, S. (2013). Mechanisms of UV-induced carcinogenesis. Nature Reviews Genetics, 14(9), 637–648. https://doi.org/10.1038/nrg3472
- Cadet, J., Mouret, S., Ravanat, J. L., & Douki, T. (2012). Photoinduced damage to cellular DNA: direct and photosensitized reactions. Photochemistry and Photobiology, 88(5), 1048–1065. https://doi.org/10.1111/j.1751-1097.2012.01099.x
- Krutmann, J., Bouloc, A., Sore, G., Bernard, B. A., & Passeron, T. (2014). The skin aging exposome. Journal of Investigative Dermatology, 134(6), 1573–1578. https://doi.org/10.1038/jid.2014.177
- Vandiver, A. R., Irizarry, R. A., Hansen, K. D., Garza, L. A., Runarsson, A., Li, X., ... & Feinberg, A. P. (2019). Large-scale methylation domains mark a functional subset of neuronally expressed genes. Nature Communications, 10(1), 1523. https://doi.org/10.1038/s41467-019-09491-5
- Oikawa, S., Tada-Oikawa, S., & Kawanishi, S. (2003). Site-specific DNA damage at the GGG sequence by UVA radiation with endogenous photosensitizers. Nucleic Acids Research, 31(11), 2755–2762. https://doi.org/10.1093/nar/gkg593
- Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2017). Cellular senescence in aging and age-related disease: from mechanisms to therapy. Cell, 169(6), 1000–1011. https://doi.org/10.1016/j.cell.2017.10.005
- Schroeder, P., Gremmel, T., Berneburg, M., & Krutmann, J. (2009). Partial depletion of mitochondrial DNA from human skin fibroblasts induces a gene expression profile resembling chronologically aged skin. Journal of Investigative Dermatology, 128(9), 2297–2303. https://doi.org/10.1111/j.1600-0625.2009.00912.x
- Gordon, J. R. S., & Brieva, J. C. (2012). Unilateral dermatoheliosis. JAMA Dermatology, 148(12), 1403. https://doi.org/10.1001/jamadermatol.2014.4837
- Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., ... & Slavich, G. M. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25(12), 1822–1832. https://doi.org/10.1038/s41577-019-0225-y
- Fell, G. L., Robinson, K. C., Mao, J., Woolf, C. J., & Fisher, D. E. (2014). Skin beta-endorphin mediates addiction to UV light. Cell Reports, 8(6), 1527–1534. https://doi.org/10.1016/j.celrep.2014.05.041
- Hughes, M. C., Williams, G. M., Baker, P., & Green, A. C. (2013). Sunscreen and prevention of skin aging: a randomized trial. Annals of Internal Medicine, 158(11), 781–790. https://doi.org/10.7326/0003-4819-158-11-201306040-00002
- Diffey, B. L. (2009). Sun protection with clothing. British Journal of Dermatology, 161(Suppl 3), 54–63. https://doi.org/10.1111/j.1365-2133.2009.09548.x
- Pullar, J. M., Carr, A. C., & Vissers, M. C. M. (2011). The roles of vitamin C in skin health. Free Radical Biology and Medicine, 51(7), 1239–1246. https://doi.org/10.1016/j.freeradbiomed.2011.11.011
- Chen, A. C., Martin, A. J., Choy, B., Fernandez-Penas, P., Dalziell, R. A., McKenzie, C. A., ... & Damian, D. L. (2015). A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine, 373(17), 1618–1626. https://doi.org/10.1056/NEJMoa1506197
- Kang, S., Bergfeld, W., Gottlieb, A. B., Hickman, J., Humeniuk, J., Kempers, S., ... & Griffiths, C. E. M. (1999). Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin. Archives of Dermatology, 135(12), 1479–1488. https://doi.org/10.1001/archderm.135.12.1479
- Chung, C. L., Lawrence, I., Hoffman, M., Elgindi, D., Nadhan, K., Potnis, M., ... & Bhanu, N. V. (2022). Topical rapamycin reduces markers of senescence and aging in human skin. Science Advances, 8(18), eadd6162. https://doi.org/10.1126/sciadv.add6162
- Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281. https://doi.org/10.1056/NEJMra070553
- Liu, D., Fernandez, B. O., Hamilton, A., Lang, N. N., Gallagher, J. M., Newby, D. E., ... & Feelisch, M. (2014). UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase activity and vitamin D. Journal of the American Heart Association, 3(3), e000017. https://doi.org/10.1161/JAHA.113.000017